About Careers MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Determiner for Agressive Prostate Cancer

by Rathi Manohar on July 14, 2010 at 6:45 PM
Font : A-A+

Determiner for Agressive Prostate Cancer

A determiner that indicates prostate cancer aggressiveness has been discovered by researchers who believe that this will lead to better diagnosis and treatment.

The study, led by Ze'ev Ronai, at Sanford-Burnham Medical Research Institute (Sanford-Burnham), appears in the journal Cancer Cell.

Advertisement

The research uncovers a protein named Siah2, which initiates a cascade of molecular events that turn a non-malignant tumour into a metastatic neuroendocrine tumour.

Dr. Ronai, associate director of Sanford-Burnham's National Cancer Institute-designated Cancer Center, said: "In identifying this protein pathway, which determines the formation of neuroendocrine tumors, we've identified new markers that can be used to distinguish the dangerous cells and find new targets for therapy."
Advertisement

In collaboration with four other medical centres across the US, Dr. Ronai and his colleagues analyzed human prostate cancer samples and found that Siah2 and the other proteins it triggers is detected more often in the aggressive neuroendocrine forms of prostate tumors than in other types. By acting as markers for particularly aggressive prostate cancers, Siah2 and its partners could provide doctors with an early warning sign for tumors that are likely to metastasize.

To further validate these findings, the Siah2 gene was inactivated in mice already prone to developing aggressive prostate tumors. Although benign growths still appeared, they failed to develop into neuroendocrine tumors.

First author Jianfei Qi, postdoctoral researcher in Dr. Ronai's laboratory, said: "When we inhibit the Siah2 pathway in mice, we eliminate the neuroendocrine-type cells from the prostate tumours. Since prostate cancers containing neuroendocrine-type cells are resistant to current therapies, we are pleased to find that targeting Siah2 might provide an alternate approach to treating this disease."

Members of the Sanford-Burnham research team are now looking for chemical compounds that inhibit the activity of Siah2 or other proteins along the chain.

They hope to find a new drug that will block the series of molecular events leading to the formation of neuroendocrine-type cancer cells, thus keeping prostate tumors in check.

Source: ANI
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
World Disability Day 2022 - The Role of Innovative Transformation
Diet and Oral Health: The Sugary Connection May Become Sour
World AIDS Day 2022 - Equalize!
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Prostate Cancer Cancer and Homeopathy Trans-Urethral Resection of the Prostate Prostate Cancer Facts Cancer Facts Cancer Tattoos A Body Art Prostate Cancer: Treatment Options Prostate Specific Antigen [PSA] Medical Management of Prostate Cancer 

Most Popular on Medindia

Diaphragmatic Hernia Vent Forte (Theophylline) Turmeric Powder - Health Benefits, Uses & Side Effects Drug Interaction Checker Nutam (400mg) (Piracetam) How to Reduce School Bag Weight - Simple Tips Drug - Food Interactions Accident and Trauma Care Calculate Ideal Weight for Infants A-Z Drug Brands in India
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

Determiner for Agressive Prostate Cancer Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests